Provided by Tiger Fintech (Singapore) Pte. Ltd.

Progyny

23.14
+0.80003.58%
Volume:1.04M
Turnover:23.74M
Market Cap:1.98B
PE:40.60
High:23.22
Open:22.42
Low:22.36
Close:22.34
Loading ...

Company Profile

Company Name:
Progyny
Exchange:
NASDAQ
Establishment Date:
2008
Employees:
678
Office Location:
1359 Broadway,New York,New York,United States
Zip Code:
10018
Fax:
- -
Introduction:
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Directors

Name
Position
David Schlanger
Chief Executive Officer and Director
Beth Seidenberg
Chair of the Board of Director
Cheryl Scott
Director
Fred E. Cohen
Director
Jeff Park
Director
Kevin Gordon
Director
Norman Payson
Director

Shareholders

Name
Position
David Schlanger
Chief Executive Officer and Director
Jennifer Bealer
Executive Vice President, General Counsel
Karin Ajmani
Executive Vice President, Chief of Strategic Development
Lisa Greenbaum
Executive Vice President, Chief Client Officer
Peter Anevski
President, Chief Financial and Operating Officer